A Phase 2 clinical trial published in the New England Journal of Medicine in 2023 reported mean body weight reductions of approximately 24% at 48 weeks at the highest studied dose
You can also discuss finding a registered dietitian or nutritionist to help develop an eating plan that works for you
"It's important to note that these Healthy Choice products weren't made specifically for GLP-1 users they're just being badged as appropriate for GLP-1 users," says Alexandra Sowa, MD, an internal medicine doctor specializing in preventative health, nutrition, and obesity medicine and the author of the forthcoming book The Ozempic Revolution
See all patient experiences switching from Tirzepatide to Retatrutide Why Consider Switching There are a few practical reasons you might be thinking about switching from tirzepatide to retatrutide
Retatrutide has demonstrated a generally favorable safety profile across Phase 2 and Phase 3 clinical trials
Always involve your prescribing physician in any decision to pause medication